Electrically Active Immune-mediated Rippling Muscle Disease Preceding Breast Cancer
Authors:
- Brent P. GoodmanBGBrent P. Goodman
- Margherita MiloneMMMargherita Milone
- 1 May 2012
- journal article
- case report
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 18 (3) , 155-158
Abstract
Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability clinically characterized by painful muscle stiffness, rippling phenomenon, percussion-induced muscle mounding, and rapid contraction. RMD is typically considered to be electrically silent, but electrical activity during the muscle rippling has been occasionally described. RMD could be genetically determined or immune-mediated (iRMD). The association between cancer and iRMD is extremely rare. We present here a patient with electrically active iRMD preceding the diagnosis of breast cancer. The patient had acetylcholine receptor binding antibodies but no clinical or electrophysiological signs of myasthenia. Muscle biopsy revealed inflammatory changes and a mosaic distribution of sarcolemmal caveolin-3 deficiency. Sequencing of caveolin-3 gene detected no mutation. Immunotherapy led to the resolution of the RMD and disappearance of the serum acetylcholine receptor antibodies. The abnormal electrical activity in this patient suggests that an acquired neuromuscular hyperexcitability syndrome represents a continuum of disorders. The close temporal relationship between the onset of iRMD and the diagnosis of breast cancer raises the possibility that iRMD might be paraneoplastic.Keywords
This publication has 29 references indexed in Scilit:
- Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodiesNeuromuscular Disorders, 2011
- Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN MutationsPLOS Genetics, 2010
- Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriersMuscle & Nerve, 2010
- Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophyJournal of Clinical Investigation, 2009
- Caveolinopathies: from the biology of caveolin-3 to human diseasesEuropean Journal of Human Genetics, 2009
- Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in twoNeuromuscular Disorders, 2009
- Truncation of Caveolin-3 causes autosomal-recessive Rippling Muscle DiseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Autosomal recessive rippling muscle disease with homozygous CAV3 mutationsAnnals of Neurology, 2005
- Rippling muscle disease: A reviewMuscle & Nerve, 2002
- Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle diseaseNature Genetics, 2001